Citations (80)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
Yoshinari Nakatsuka, Tomohiro Handa, Yuji Nakamoto, Tomomi Nobashi, Hajime Yoshihuji, Kiminobu Tanizawa, Kohei Ikezoe, Akihiko Sokai, Takeshi Kubo, Toyohiro Hirai, Kazuo Chin, Kaori Togashi, Tsuneyo Mimori & Michiaki Mishima. (2015) Total lesion glycolysis as an IgG4-related disease activity marker. Modern Rheumatology 25:4, pages 579-584.
Read now
Read now
Bianca A. W. Hoeben, Johan Bussink, Esther G. C. Troost, Wim J. G. Oyen & Johannes H. A. M. Kaanders. (2013) Molecular PET imaging for biology-guided adaptive radiotherapy of head and neck cancer. Acta Oncologica 52:7, pages 1257-1271.
Read now
Read now
Articles from other publishers (78)
Sheng-Chieh Chan, Chih-Hua Yeh, Shu-Hang Ng, Chien-Yu Lin, Jen-Hung Wang, Joseph Tung-Chieh Chang, Nai-Ming Cheng, Kai-Ping Chang & Jason Chia-Hsun Hsieh. (2022) Prospective Investigation of 18FDG-PET/MRI with Intravoxel Incoherent Motion Diffusion-Weighted Imaging to Assess Survival in Patients with Oropharyngeal or Hypopharyngeal Carcinoma. Cancers 14:24, pages 6104.
Crossref
Crossref
Caiyun Huang, Lingyu Zhang, Zhaoting Meng, Tianbin Song, Suresh Kumar Mukherji, Xiaohong Chen, Jie Lu & Junfang Xian. (2022) Prognostic Value of 18F-Fluorodeoxyglucose–Positron Emission Tomography/Magnetic Resonance Imaging in Patients With Hypopharyngeal Squamous Cell Carcinoma. Journal of Computer Assisted Tomography 46:6, pages 968-977.
Crossref
Crossref
Wai-Chung Wong. (2022) Focal Nasopharyngeal Activity Detected on [18F]FDG PET/CT: Clinical Implications and Comparison of Metabolic Parameters for Prediction of Malignancy. Nuclear Medicine and Molecular Imaging.
Crossref
Crossref
Kevin Diao, Theresa P. Nguyen, Amy C. Moreno, Jay P. Reddy, Adam S. Garden, Catherine H. Wang, Samuel Tung, Congjun Wang, Xin A. Wang, David I. Rosenthal, Clifton D. Fuller, Gary B. Gunn, Steven J. Frank, William H. Morrison, Shalin J. Shah, Anna Lee, Michael T. Spiotto, Shirley Y. Su, Renata Ferrarotto & Jack Phan. (2021) Stereotactic body ablative radiotherapy for reirradiation of small volume head and neck cancers is associated with prolonged survival: Large, single‐institution, modern cohort study. Head & Neck 43:11, pages 3331-3344.
Crossref
Crossref
Seung Hwan Moon, Young Seok Cho & Joon Young Choi. (2021) KSNM60 in Clinical Nuclear Oncology. Nuclear Medicine and Molecular Imaging 55:5, pages 210-224.
Crossref
Crossref
Hale Aslan, Gul Cekin, Ercan Pinar, Mustafa Yazir, Abdulkadir Imre, Murat Songu, Akif Islek, Ibrahim Aladag & Ismail Semih Oncel. (2021) Prognostic value of 18F-FDG PET/CT parameters and histopathologic variables in head and neck cancer. Brazilian Journal of Otorhinolaryngology 87:4, pages 452-456.
Crossref
Crossref
Huan-Chun Lin, Sheng-Chieh Chan, Nai-Ming Cheng, Chun-Ta Liao, Cheng-Lung Hsu, Hung-Ming Wang, Chien-Yu Lin, Joseph Tung-Chieh Chang, Shu-Hang Ng, Lan-Yan Yang & Tzu-Chen Yen. (2020) Pretreatment 18F-FDG PET/CT texture parameters provide complementary information to Epstein-Barr virus DNA titers in patients with metastatic nasopharyngeal carcinoma. Oral Oncology 104, pages 104628.
Crossref
Crossref
Jian Q. Yu & Yamin Dou. 2020. Renal Cancer. Renal Cancer
99
118
.
Chih-Kai Wong, Sheng-Chieh Chan, Shu-Hang Ng, Chia-Hsun Hsieh, Nai-Ming Cheng, Tzu-Chen Yen & Chun-Ta Liao. (2019) Textural features on 18F-FDG PET/CT and dynamic contrast-enhanced MR imaging for predicting treatment response and survival of patients with hypopharyngeal carcinoma. Medicine 98:33, pages e16608.
Crossref
Crossref
Hyun Chang, Soo Jin Lee, Jin Lim, Jong Seok Lee, Yu Jung Kim & Won Woo Lee. (2019) Prognostic significance of metabolic parameters measured by 18F-FDG PET/CT in limited-stage small-cell lung carcinoma. Journal of Cancer Research and Clinical Oncology 145:5, pages 1361-1367.
Crossref
Crossref
Narayana Subramaniam, Deepak Balasubramanian, P Shanmuga Sundaram, Samskruthi Murthy, Krishnakumar Thankappan & Subramania Iyer. (2021) Role of pretreatment fluorodeoxyglucose positron emission tomography quantitative parameters in prognostication of head-and-neck squamous cell carcinoma. Indian Journal of Medical and Paediatric Oncology 40:01, pages 21-27.
Crossref
Crossref
Eiichiro Okazaki, Joji Kawabe, Masahiro Oishi, Masako Hosono, Shigeaki Higashiyama, Yuichi Teranishi, Susumu Shiomi, Hiroyoshi Iguchi & Yukio Miki. (2018) Prognostic significance of pretreatment 18F‐fluorodeoxyglucose positron emission tomography evaluation using metabolic tumor volume of the primary tumor and lymph nodes in advanced hypopharyngeal cancer. Head & Neck.
Crossref
Crossref
Wenchao Ma, Minshu Wang, Xiaofeng Li, Hui Huang, Yanjia Zhu, Xiuyu Song, Dong Dai & Wengui Xu. (2018) Quantitative 18F‑FDG PET analysis in survival rate prediction of patients with non‑small cell lung cancer. Oncology Letters.
Crossref
Crossref
Chih-Hua Yeh, Gigin Lin, Jiun-Jie Wang, Chien-Yu Lin, Shang-Yueh Tsai, Yu-Chun Lin, Yi-Ming Wu, Sheung-Fat Ko, Hung-Ming Wang, Sheng-Chieh Chan, Tzu-Chen Yen, Chun-Ta Liao & Shu-Hang Ng. (2017) Predictive value of 1H MR spectroscopy and 18F-FDG PET/CT for local control of advanced oropharyngeal and hypopharyngeal squamous cell carcinoma receiving chemoradiotherapy: a prospective study. Oncotarget 8:70, pages 115513-115525.
Crossref
Crossref
Sheng-Chieh Chan, Nai-Ming Cheng, Chia-Hsun Hsieh, Shu-Hang Ng, Chien-Yu Lin, Tzu-Chen Yen, Cheng-Lung Hsu, Hung-Ming Wan, Chun-Ta Liao, Kai-Ping Chang & Jiun-Jie Wang. (2017) Multiparametric imaging using 18F-FDG PET/CT heterogeneity parameters and functional MRI techniques: prognostic significance in patients with primary advanced oropharyngeal or hypopharyngeal squamous cell carcinoma treated with chemoradiotherapy. Oncotarget 8:37, pages 62606-62621.
Crossref
Crossref
Joël Castelli, Adrien Depeursinge, Berardino de Bari, Anne Devillers, Renaud de Crevoisier, Jean Bourhis & John O. Prior. (2017) Metabolic Tumor Volume and Total Lesion Glycolysis in Oropharyngeal Cancer Treated With Definitive Radiotherapy. Clinical Nuclear Medicine 42:6, pages e281-e285.
Crossref
Crossref
Shih-Neng Yang, Yu-Rou Chiou, Geoffrey G. Zhang, Kuei-Ting Chou & Tzung-Chi Huang. (2017) The clinical outcome correlations between radiation dose and pretreatment metabolic tumor volume for radiotherapy in head and neck cancer. Medicine 96:26, pages e7186.
Crossref
Crossref
Myo Min, Peter Lin, Gary Liney, Mark Lee, Dion Forstner, Allan Fowler & Lois Holloway. (2017) A review of the predictive role of functional imaging in patients with mucosal primary head and neck cancer treated with radiation therapy. Journal of Medical Imaging and Radiation Oncology 61:1, pages 99-123.
Crossref
Crossref
Shu-Hang Ng, Chun-Ta Liao, Chien-Yu Lin, Sheng-Chieh Chan, Yu-Chun Lin, Tzu-Chen Yen, Joseph Tung-Chieh Chang, Sheung-Fat Ko, Kang-Hsing Fan, Hung-Ming Wang, Lan-Yan Yang & Jiun-Jie Wang. (2016) Dynamic contrast-enhanced MRI, diffusion-weighted MRI and 18F-FDG PET/CT for the prediction of survival in oropharyngeal or hypopharyngeal squamous cell carcinoma treated with chemoradiation. European Radiology 26:11, pages 4162-4172.
Crossref
Crossref
Giovanni Cammaroto, Natale Quartuccio, Alessandro Sindoni, Francesca Di Mauro & Federico Caobelli. (2015) The role of PET/CT in the management of patients affected by head and neck tumors: a review of the literature. European Archives of Oto-Rhino-Laryngology 273:8, pages 1961-1973.
Crossref
Crossref
Irene A. Burger, Ruben Casanova, Seraina Steiger, Lars Husmann, Paul Stolzmann, Martin W. Huellner, Alessandra Curioni, Sven Hillinger, C. Ross Schmidtlein & Alex Soltermann. (2016)
18
F-FDG PET/CT of Non–Small Cell Lung Carcinoma Under Neoadjuvant Chemotherapy: Background-Based Adaptive-Volume Metrics Outperform TLG and MTV in Predicting Histopathologic Response
. Journal of Nuclear Medicine 57:6, pages 849-854.
Crossref
Crossref
Matthew C. Ward, Ankeet Shah, Shlomo A. Koyfman, Tobenna Nwizu, Joseph Scharpf, Brian Burkey, Eric Lamarre, David J. Adelstein, John F. Greskovich & Ping Xia. (2015) The prognostic value of pretreatment FDG-PET parameters in HPV-associated oropharynx cancer. Journal of Radiation Oncology 5:2, pages 161-167.
Crossref
Crossref
Bum Soo Kim, Seong-Jang Kim & Kyoungjune Pak. (2016) Diagnostic value of metabolic heterogeneity as a reliable parameter for differentiating malignant parotid gland tumors. Annals of Nuclear Medicine 30:5, pages 346-354.
Crossref
Crossref
Ronan Abgral, Gérald Valette, Philippe Robin, Jean Rousset, Nathalie Keromnes, Pierre-Yves Le Roux, Rémi Marianowski & Pierre-Yves Salaün. (2016)
Prognostic evaluation of percentage variation of metabolic tumor burden calculated by dual-phase
18
FDG PET-CT imaging in patients with head and neck cancer
. Head & Neck 38:S1, pages E600-E606.
Crossref
Crossref
Taha S. Meraj, Suyash Mohan & Gaurang V. Shah. 2016. Head and Neck Cancer. Head and Neck Cancer
243
264
.
Ozlem Ozkaya Akagunduz, Recep Savas, Deniz Yalman, Kenan Kocacelebi & Mustafa Esassolak. (2015) Can adaptive threshold-based metabolic tumor volume (MTV) and lean body mass corrected standard uptake value (SUL) predict prognosis in head and neck cancer patients treated with definitive radiotherapy/chemoradiotherapy?. Nuclear Medicine and Biology 42:11, pages 899-904.
Crossref
Crossref
Yang Yu, Hui Guan, Li-Gang Xing & Yong-Bing Xiang. (2015) Role of Gross Tumor Volume in the Prognosis of Non–small Cell Lung Cancer Treated With 3D Conformal Radiotherapy: A Meta-analysis. Clinical Therapeutics 37:10, pages 2256-2266.
Crossref
Crossref
Masahiro Kikuchi, Sho Koyasu, Shogo Shinohara, Yu Usami, Yukihiro Imai, Megumu Hino, Kyo Itoh, Risa Tona, Yuji Kanazawa, Ippei Kishimoto, Hiroyuki Harada & Yasushi Naito. (2015)
Prognostic value of pretreatment
18
F-fluorodeoxyglucose positron emission tomography/CT volume-based parameters in patients with oropharyngeal squamous cell carcinoma with known p16 and p53 status
. Head & Neck 37:10, pages 1524-1531.
Crossref
Crossref
C Jentsch, B Beuthien-Baumann, E G C Troost & G Shakirin. (2015) Validation of functional imaging as a biomarker for radiation treatment response. The British Journal of Radiology 88:1051, pages 20150014.
Crossref
Crossref
Ting Shen, Lin-Quan Tang, Dong-Hua Luo, Qiu-Yan Chen, Pei-Jing Li, Dong-Mei Mai, Shan-Shan Guo, Li-Ting Liu, Chao-Nan Qian, Xiang Guo, Mu-Sheng Zeng, Hao-Yuan Mo & Hai-Qiang Mai. (2015) Different Prognostic Values of Plasma Epstein-Barr Virus DNA and Maximal Standardized Uptake Value of 18F-FDG PET/CT for Nasopharyngeal Carcinoma Patients with Recurrence. PLOS ONE 10:4, pages e0122756.
Crossref
Crossref
S. Jun, H. Kim & H.-Y. Nam. (2018) A new method for segmentation of FDG PET metabolic tumour volume using the peritumoural halo layer and a 10-step colour scale. Nuklearmedizin 54:06, pages 272-285.
Crossref
Crossref
Kyoungjune Pak, Gi Jeong Cheon, Keon Wook Kang, June-Key Chung, E. Edmund Kim & Dong Soo Lee. (2015) Prognostic Value of SUVmean in Oropharyngeal and Hypopharyngeal Cancers. Clinical Nuclear Medicine 40:1, pages 9-13.
Crossref
Crossref
Shu-Hang Ng, Chien-Yu Lin, Sheng-Chieh Chan, Yu-Chun Lin, Tzu-Chen Yen, Chun-Ta Liao, Joseph Tung-Chieh Chang, Sheung-Fat Ko, Hung- Ming Wang, Chee-Jen Chang & Jiun-Jie Wang. (2014) Clinical Utility of Multimodality Imaging with Dynamic Contrast-Enhanced MRI, Diffusion-Weighted MRI, and 18F-FDG PET/CT for the Prediction of Neck Control in Oropharyngeal or Hypopharyngeal Squamous Cell Carcinoma Treated with Chemoradiation. PLoS ONE 9:12, pages e115933.
Crossref
Crossref
Tomasz Rutkowski. (2014) The role of tumor volume in radiotherapy of patients with head and neck cancer. Radiation Oncology 9:1.
Crossref
Crossref
Jong-Lyel Roh, Jae Seung Kim, Byung Chul Kang, Kyung-Ja Cho, Sang-wook Lee, Sung-Bae Kim, Seung-Ho Choi, Soon Yuhl Nam & Sang Yoon Kim. (2014) Clinical significance of pretreatment metabolic tumor volume and total lesion glycolysis in hypopharyngeal squamous cell carcinomas. Journal of Surgical Oncology 110:7, pages 869-875.
Crossref
Crossref
Young-Ho Yoon, Seok-Hwan Lee, Sung-Lyong Hong, Seong-Jang Kim, Hwan-Jung Roh & Kyu-Sup Cho. (2014) Prognostic value of metabolic tumor volume as measured by fluorine-18-fluorodeoxyglucose positron emission tomography/computed tomography in nasopharyngeal carcinoma. International Forum of Allergy & Rhinology 4:10, pages 845-850.
Crossref
Crossref
Qi Shi, Zhongyi Yang, Yingjian Zhang & Chaosu Hu. (2014) Adding Maximum Standard Uptake Value of Primary Lesion and Lymph Nodes in 18F-Fluorodeoxyglucose PET Helps Predict Distant Metastasis in Patients with Nasopharyngeal Carcinoma. PLoS ONE 9:7, pages e103153.
Crossref
Crossref
Moon Ki Choi, Joon Young Choi, Jeeyun Lee, Jin Seok Heo, Seong Ho Choi, Dong Wook Choi, Kyu Taek Lee, Jong Kyun Lee, Kwang Hyuck Lee, Joon Oh Park, Young Suk Park & Ho Yeong Lim. (2014) Prognostic and predictive value of metabolic tumor volume on 18F-FDG PET/CT in advanced biliary tract cancer treated with gemcitabine/oxaliplatin with or without erlotinib. Medical Oncology 31:7.
Crossref
Crossref
Irene A. Burger, Hebert Alberto Vargas, Aditya Apte, Bradley J. Beattie, John L. Humm, Mithat Gonen, Steven M. Larson & C. Ross Schmidtlein. (2014) PET quantification with a histogram derived total activity metric: Superior quantitative consistency compared to total lesion glycolysis with absolute or relative SUV thresholds in phantoms and lung cancer patients. Nuclear Medicine and Biology 41:5, pages 410-418.
Crossref
Crossref
Hong Jae Jo, Seong-Jang Kim, In Joo Kim & Sojung Kim. (2014) Predictive value of volumetric parameters measured by F-18 FDG PET/CT for lymph node status in patients with surgically resected rectal cancer. Annals of Nuclear Medicine 28:3, pages 196-202.
Crossref
Crossref
Ronan Abgral, Nathalie Keromnes, Philippe Robin, Pierre-Yves Le Roux, David Bourhis, Xavier Palard, Jean Rousset, Gérald Valette, Rémi Marianowski & Pierre-Yves Salaün. (2013) Prognostic value of volumetric parameters measured by 18F-FDG PET/CT in patients with head and neck squamous cell carcinoma. European Journal of Nuclear Medicine and Molecular Imaging 41:4, pages 659-667.
Crossref
Crossref
In Sun Ryu, Jae Seung Kim, Jong-Lyel Roh, Kyung-Ja Cho, Seung-Ho Choi, Soon Yuhl Nam & Sang Yoon Kim. (2013) Prognostic significance of preoperative metabolic tumour volume and total lesion glycolysis measured by 18F-FDG PET/CT in squamous cell carcinoma of the oral cavity. European Journal of Nuclear Medicine and Molecular Imaging 41:3, pages 452-461.
Crossref
Crossref
M. Picchio, M. Kirienko, P. Mapelli, I. Dell’Oca, E. Villa, F. Gallivanone, L. Gianolli, C. Messa & I. Castiglioni. (2013) Predictive value of pre-therapy 18F-FDG PET/CT for the outcome of 18F-FDG PET-guided radiotherapy in patients with head and neck cancer. European Journal of Nuclear Medicine and Molecular Imaging 41:1, pages 21-31.
Crossref
Crossref
William M. Mendenhall, Anthony A. Mancuso, Primoz Strojan, Jonathan J. Beitler, Carlos Suarez, Tsair-Fwu Lee, Johannes A. Langendijk, June Corry, Avraham Eisbruch, Alessandra Rinaldo & Alfio Ferlito. (2013) Impact of primary tumor volume on local control after definitive radiotherapy for head and neck cancer. Head & Neck, pages n/a-n/a.
Crossref
Crossref
Shu-Hang Ng, Chien-Yu Lin, Sheng-Chieh Chan, Tzu-Chen Yen, Chun-Ta Liao, Joseph Tung-Chieh Chang, Sheung-Fat Ko, Hung-Ming Wang, Shiang-Fu Huang, Yu-Chun Lin & Jiun-Jie Wang. (2013) Dynamic Contrast-Enhanced MR Imaging Predicts Local Control in Oropharyngeal or Hypopharyngeal Squamous Cell Carcinoma Treated with Chemoradiotherapy. PLoS ONE 8:8, pages e72230.
Crossref
Crossref
Jessica DavisonGustavo MercierGregory RussoRathan M. Subramaniam. (2013) PET-Based Primary Tumor Volumetric Parameters and Survival of Patients With Non—Small Cell Lung Carcinoma. American Journal of Roentgenology 200:3, pages 635-640.
Crossref
Crossref
Yasser G. Abd El-Hafez, Hosna M. Moustafa, Haytham F. Khalil, Chun-Ta Liao & Tzu-Chen Yen. (2013) Total lesion glycolysis: A possible new prognostic parameter in oral cavity squamous cell carcinoma. Oral Oncology 49:3, pages 261-268.
Crossref
Crossref
Adam A. Garsa, Albert J. Chang, Todd DeWees, Christopher R. Spencer, Douglas R. Adkins, Farrokh Dehdashti, Hiram A. Gay & Wade L. Thorstad. (2012) Prognostic value of 18F-FDG PET metabolic parameters in oropharyngeal squamous cell carcinoma. Journal of Radiation Oncology 2:1, pages 27-34.
Crossref
Crossref
Hyung-Jun Im, Yu Kyeong Kim, Yong-il Kim, Jong Jin Lee, Won Woo Lee & Sang Eun Kim. (2012) Usefulness of Combined Metabolic–Volumetric Indices of 18F-FDG PET/CT for the Early Prediction of Neoadjuvant Chemotherapy Outcomes in Breast Cancer. Nuclear Medicine and Molecular Imaging 47:1, pages 36-43.
Crossref
Crossref
G.C. Park, J.S. Kim, J.-L. Roh, S.-H. Choi, S.Y. Nam & S.Y. Kim. (2013) Prognostic value of metabolic tumor volume measured by 18F-FDG PET/CT in advanced-stage squamous cell carcinoma of the larynx and hypopharynx. Annals of Oncology 24:1, pages 208-214.
Crossref
Crossref
Sheng-Chieh Chan, Cheng-Lung Hsu, Tzu-Chen Yen, Shu-Hang Ng, Chun-Ta Liao & Hung-Ming Wang. (2013) The role of 18F-FDG PET/CT metabolic tumour volume in predicting survival in patients with metastatic nasopharyngeal carcinoma. Oral Oncology 49:1, pages 71-78.
Crossref
Crossref
Christophe Van de Wiele, Vibeke Kruse, Peter Smeets, Mike Sathekge & Alex Maes. (2012) Predictive and prognostic value of metabolic tumour volume and total lesion glycolysis in solid tumours. European Journal of Nuclear Medicine and Molecular Imaging 40:2, pages 290-301.
Crossref
Crossref
Jian Q. Yu & Yamin Dou. 2013. Renal Cancer. Renal Cancer
93
111
.
Cem Parlak, Erkan Topkan, Cem Onal, Mehmet Reyhan & Ugur Selek. (2012) Prognostic value of gross tumor volume delineated by FDG-PET-CT based radiotherapy treatment planning in patients with locally advanced pancreatic cancer treated with chemoradiotherapy. Radiation Oncology 7:1.
Crossref
Crossref
Su Woong Yoo, Jahae Kim, Ari Chong, Seong-Young Kwon, Jung-Joon Min, Ho-Chun Song & Hee-Seung Bom. (2012) Metabolic Tumor Volume Measured by F-18 FDG PET/CT can Further Stratify the Prognosis of Patients with Stage IV Non-Small Cell Lung Cancer. Nuclear Medicine and Molecular Imaging 46:4, pages 286-293.
Crossref
Crossref
B. Shah, N. Srivastava, A. E. Hirsch, G. Mercier & R. M. Subramaniam. (2012) Intra-reader reliability of FDG PET volumetric tumor parameters: effects of primary tumor size and segmentation methods. Annals of Nuclear Medicine 26:9, pages 707-714.
Crossref
Crossref
Remy Lim, Anne Eaton, Nancy Y. Lee, Jeremy Setton, Nisha Ohri, Shyam Rao, Richard Wong, Matthew Fury & Heiko Schöder. (2012)
18
F-FDG PET/CT Metabolic Tumor Volume and Total Lesion Glycolysis Predict Outcome in Oropharyngeal Squamous Cell Carcinoma
. Journal of Nuclear Medicine 53:10, pages 1506-1513.
Crossref
Crossref
Elizabeth A. Kidd, Issam El Naqa, Barry A. Siegel, Farrokh Dehdashti & Perry W. Grigsby. (2012) FDG-PET-based prognostic nomograms for locally advanced cervical cancer. Gynecologic Oncology 127:1, pages 136-140.
Crossref
Crossref
Farzan Siddiqui, Peter F. Faulhaber, Min Yao & Quynh-Thu Le. (2012) The Application of FDG-PET as Prognostic Indicators in Head and Neck Squamous Cell Carcinoma. PET Clinics 7:4, pages 381-394.
Crossref
Crossref
Karen P. Chu, James D. Murphy, Trang H. La, Trevor E. Krakow, Andrei Iagaru, Edward E. Graves, Annie Hsu, Peter G. Maxim, Billy Loo, Daniel T. Chang & Quynh-Thu Le. (2012) Prognostic Value of Metabolic Tumor Volume and Velocity in Predicting Head-and-Neck Cancer Outcomes. International Journal of Radiation Oncology*Biology*Physics 83:5, pages 1521-1527.
Crossref
Crossref
Chia-Hung Kao, Shih-Chieh Lin, Te-Chun Hsieh, Kuo-Yang Yen, Shih-Neng Yang, Yao-Ching Wang, Ji-An Liang, Chun-Hung Hua & Shang-Wen Chen. (2012) Use of pretreatment metabolic tumour volumes to predict the outcome of pharyngeal cancer treated by definitive radiotherapy. European Journal of Nuclear Medicine and Molecular Imaging 39:8, pages 1297-1305.
Crossref
Crossref
Eric O. Aboagye, Fiona J. Gilbert, Ian N. Fleming, Ambros J. Beer, Vincent J. Cunningham, Paul K. Marsden, Dimitris Visvikis, Antony D. Gee, Ashley M. Groves, Laura M. Kenny, Gary J. Cook, Paul E. Kinahan, Melvyn Myers & Larry Clarke. (2012) Recommendations for measurement of tumour vascularity with positron emission tomography in early phase clinical trials. European Radiology 22:7, pages 1465-1478.
Crossref
Crossref
Hao Zhang, Kristen Wroblewski & Yonglin Pu. (2012) Prognostic value of tumor burden measurement using the number of tumors in non-surgical patients with non-small cell lung cancer. Acta Radiologica 53:5, pages 561-568.
Crossref
Crossref
Elizabeth H. Dibble, Ana C. Lara Alvarez, Minh-Tam Truong, Gustavo Mercier, Earl F. Cook & Rathan M. Subramaniam. (2012)
18
F-FDG Metabolic Tumor Volume and Total Glycolytic Activity of Oral Cavity and Oropharyngeal Squamous Cell Cancer: Adding Value to Clinical Staging
. Journal of Nuclear Medicine 53:5, pages 709-715.
Crossref
Crossref
Ho Seok I, Seong-Jang Kim, In Joo Kim & Keunyoung Kim. (2012) Predictive Value of Metabolic Tumor Volume Measured by 18F-FDG PET for Regional Lymph Node Status in Patients With Esophageal Cancer. Clinical Nuclear Medicine 37:5, pages 442-446.
Crossref
Crossref
Percy Lee, Jose G. Bazan, Philip W. Lavori, Dilani K. Weerasuriya, Andrew Quon, Quynh-Thu Le, Heather A. Wakelee, Edward E. Graves & Billy W. Loo. (2012) Metabolic Tumor Volume is an Independent Prognostic Factor in Patients Treated Definitively for Non–Small-Cell Lung Cancer. Clinical Lung Cancer 13:1, pages 52-58.
Crossref
Crossref
Shengri Liao, Bill C. Penney, Hao Zhang, Kenji Suzuki & Yonglin Pu. (2012) Prognostic Value of the Quantitative Metabolic Volumetric Measurement on 18F-FDG PET/CT in Stage IV Nonsurgical Small-cell Lung Cancer. Academic Radiology 19:1, pages 69-77.
Crossref
Crossref
Shengri Liao, Bill C. Penney, Kristen Wroblewski, Hao Zhang, Cassie A. Simon, Rony Kampalath, Ming-Chi Shih, Naoko Shimada, Sheng Chen, Ravi Salgia, Daniel E. Appelbaum, Kenji Suzuki, Chin-Tu Chen & Yonglin Pu. (2011) Prognostic value of metabolic tumor burden on 18F-FDG PET in nonsurgical patients with non-small cell lung cancer. European Journal of Nuclear Medicine and Molecular Imaging 39:1, pages 27-38.
Crossref
Crossref
Sheng-Chieh Chan, Joseph T. Chang, Chien-Yu Lin, Shu-Hang Ng, Hung-Ming Wang, Chun-Ta Liao, Chee-Jen Chang, Shao-Yu Lin & Tzu-Chen Yen. (2011) Clinical utility of 18F-FDG PET parameters in patients with advanced nasopharyngeal carcinoma. Nuclear Medicine Communications 32:11, pages 989-996.
Crossref
Crossref
Dongyuan Zhu, Tinghang Ma, Zuoxing Niu, Jinsong Zheng, Anqin Han, Shuqiang Zhao & Jinming Yu. (2011) Prognostic significance of metabolic parameters measured by 18F-fluorodeoxyglucose positron emission tomography/computed tomography in patients with small cell lung cancer. Lung Cancer 73:3, pages 332-337.
Crossref
Crossref
Dominic A. X. Schinagl, Paul N. Span, Wim J. Oyen & Johannes H. A. M. Kaanders. (2011) Can FDG PET predict radiation treatment outcome in head and neck cancer? Results of a prospective study. European Journal of Nuclear Medicine and Molecular Imaging 38:8, pages 1449-1458.
Crossref
Crossref
Peng Xie, Minghuan Li, Hanxi Zhao, Xindong Sun, Zheng Fu & Jinming Yu. (2011) 18F-FDG PET or PET-CT to evaluate prognosis for head and neck cancer: a meta-analysis. Journal of Cancer Research and Clinical Oncology 137:7, pages 1085-1093.
Crossref
Crossref
Maria Hentschel, Steffen Appold, Andreas Schreiber, Nasreddin Abolmaali, Andrij Abramyuk, Wolfgang Dörr, Joerg Kotzerke, Michael Baumann & Klaus Zöphel. (2011) Early FDG PET at 10 or 20 Gy under chemoradiotherapy is prognostic for locoregional control and overall survival in patients with head and neck cancer. European Journal of Nuclear Medicine and Molecular Imaging 38:7, pages 1203-1211.
Crossref
Crossref
R.N. Moule, I. Kayani, T. Prior, C. Lemon, K. Goodchild, B. Sanghera, W.L. Wong & M.I. Saunders. (2011) Adaptive 18Fluoro-2-deoxyglucose Positron Emission Tomography/Computed Tomography-based Target Volume Delineation in Radiotherapy Planning of Head and Neck Cancer. Clinical Oncology 23:5, pages 364-371.
Crossref
Crossref
Kyu-Ho Choi, Ie Ryung Yoo, Eun Ji Han, Yeon Sil Kim, Gi Won Kim, Sae Jung Na, Dong-Il Sun, So Lyung Jung, Chan-Kwon Jung, Min-Sik Kim, So-Yeon Lee & Sung Hoon Kim. (2010) Prognostic Value of Metabolic Tumor Volume Measured by 18F-FDG PET/CT in Locally Advanced Head and Neck Squamous Cell Carcinomas Treated by Surgery. Nuclear Medicine and Molecular Imaging 45:1, pages 43-51.
Crossref
Crossref
Bum Soo Kim, In Joo Kim, Seong-Jang Kim, Hyun-Yeol Nam, Kyoung June Pak, Keunyoung Kim & Man Soo Yun. (2010) The Prognostic Value of the Metabolic Tumor Volume in FIGO stage IA to IIB Cervical Cancer for Tumor Recurrence: Measured by F-18 FDG PET/CT. Nuclear Medicine and Molecular Imaging 45:1, pages 36-42.
Crossref
Crossref
Mathieu Hatt, Catherine Cheze-Le Rest, Eric O. Aboagye, Laura M. Kenny, Lula Rosso, Federico E. Turkheimer, Nidal M. Albarghach, Jean-Philippe Metges, Olivier Pradier & Dimitris Visvikis. (2010)
Reproducibility of
18
F-FDG and 3′-Deoxy-3′-
18
F-Fluorothymidine PET Tumor Volume Measurements
. Journal of Nuclear Medicine 51:9, pages 1368-1376.
Crossref
Crossref
K. Fritzsche, K. Breitenstein & D. Eßer. (2010) Patienten mit Malignomen des Oro- und Hypopharynx sowie LarynxPatients with malignancies of the oro- and hypopharynx as well as the larynx. HNO 58:8, pages 756-761.
Crossref
Crossref